Weight gain as an indicator of response to chemotherapy for oesophageal carcinoma
- 31 December 1995
- journal article
- Published by Elsevier in Clinical Oncology
- Vol. 7 (6) , 382-384
- https://doi.org/10.1016/s0936-6555(05)80010-x
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- A phase II study of mitomycin, ifosfamide and cisplatin in operable and inoperable squamous cell carcinoma of the oesophagusClinical Oncology, 1994
- Who benefits from neoadjuvant therapy of esophageal cancer?Diseases of the Esophagus, 1994
- Non-operative therapy of esophageal cancerDiseases of the Esophagus, 1994
- Mitomycin, Ifosfamide, and Cisplatin in Non-Small Cell Lung CancerOncology, 1993
- Esophageal cancer: Does preoperative chemotherapy make a difference?Journal of Surgical Oncology, 1992
- Preoperative chemotherapy, surgical resection, and selective postoperative therapy for squamous cell carcinoma of the esophagusThe Annals of Thoracic Surgery, 1988
- Reporting results of cancer treatmentCancer, 1981